Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;144(15):3305-3315.
doi: 10.1017/S0950268816001436. Epub 2016 Jul 29.

Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome

Affiliations

Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome

A Kuehne et al. Epidemiol Infect. 2016 Nov.

Abstract

Shiga toxin-producing Escherichia coli (STEC) is an important cause of gastroenteritis (GE) and haemolytic uraemic syndrome (HUS). Incidence of STEC illness is largely underestimated in notification data, particularly of serogroups other than O157 ('non-O157'). Using HUS national notification data (2008-2012, excluding 2011), we modelled true annual incidence of STEC illness in Germany separately for O157 and non-O157 STEC, taking into account the groups' different probabilities of causing bloody diarrhoea and HUS, and the resulting difference in their under-ascertainment. Uncertainty of input parameters was evaluated by stochastic Monte Carlo simulations. Median annual incidence (per 100 000 population) of STEC-associated HUS and STEC-GE was estimated at 0·11 [95% credible interval (CrI) 0·08-0·20], and 35 (95% CrI 12-145), respectively. German notification data underestimated STEC-associated HUS and STEC-GE incidences by factors of 1·8 and 32·3, respectively. Non-O157 STEC accounted for 81% of all STEC-GE, 51% of all bloody STEC-GE and 32% of all STEC-associated HUS cases. Non-O157 serogroups dominate incidence of STEC-GE and contribute significantly to STEC-associated HUS in Germany. This might apply to many other countries considering European surveillance data on HUS. Non-O157 STEC should be considered in parallel with STEC O157 when searching aetiology in patients with GE or HUS, and accounted for in modern surveillance systems.

Keywords: Escherichia coli O157; Burden of illness; Monte Carlo method; enterohaemorrhagic Escherichia coli; incidence.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Modelling true annual incidence of O157 and non-O157 STEC illness in Germany based on notification data of haemolytic uraemic syndrome (HUS).
Fig. 2.
Fig. 2.
Results of the systematic review to identify input parameters for the estimation of the true incidence of O157 and non-O157 STEC illness in Germany based on notification data of haemolytic uraemic syndrome (HUS).
Fig. 3.
Fig. 3.
Sensitivity analysis of influence of input parameters on frequency of STEC-GE in Germany based on notification data of haemolytic uraemic syndrome (HUS).

Similar articles

Cited by

References

    1. Boerlin P, et al. Associations between virulence factors of shiga toxin-producing Escherichia coli and disease in humans. Journal of Clinical Microbiology 1999; 37: 497–503. - PMC - PubMed
    1. Preussel K, et al. Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups – except O104. PLoS ONE 2013; 8: e78180. - PMC - PubMed
    1. Hadler JL, et al. Ten-year trends and risk factors for non-o157 shiga toxin-producing Escherichia coli found through shiga toxin testing, Connecticut, 2000–2009. Journal of Clinical Infectious Diseases 2011; 53: 269–276. - PubMed
    1. Hedican EB, et al. Characteristics of O157 versus non-O157 shiga toxin-producing Escherichia coli infections in Minnesota, 2000–2006. Journal of Clinical Infectious Diseases 2009; 49: 358–364. - PubMed
    1. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086. - PubMed

MeSH terms